🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
NCT06974968Spinal Cord Injury, Safety, Efficacy, Clinical Trial
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Phase 2
60
Guangzhou
2028-05-25
By invitation
Adaptive Neoadjuvant Therapy for Esophageal Cancer
NCT06990178Esophageal Carcinoma, Neoadjuvant Therapy
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Not applicable
43
Shenzhen
2028-03-01
Not yet open
Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction
NCT07044700Heart Failure of Reduced Ejection Fraction (HFrEF)
DrugDapagliflozin
Boehringer Ingelheim
Observational
5,000
Beijing
2028-01-31
Not yet open
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
NCT07382375Aortic Aneurysm and Dissection
DrugUlinastatin
Nanjing Medical University
Not applicable
300
Beijing, Changzhou, Chengdu, Fuzhou, Guangzhou, Nanchang, Nanjing, Shanghai
2027-12-31
Not yet open
To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria
NCT07318909Phenylketonuria (PKU)
Gritgen Therapeutics Co., Ltd.
Phase EARLY_PHASE1
9
Hefei
2027-12-31
Not yet open
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
NCT07789483Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
DrugALXN2220
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Beijing, Chongqing, Guangzhou, Guiyang, Harbin, Wuhan, Changsha, Nanjing
2027-11-23
Not yet open
Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor
NCT07707882Tenosynovial Giant Cell Tumor, Diffuse
DrugPimicotinib
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
84
Hangzhou
2027-10-01
Not yet open
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
NCT07691645HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine, ICG (Indocyanine Green), Overall Survival (All-cause Mortality)
Xiang-Qian
Phase 2
120
Hangzhou
2027-09-01
Not yet open
iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder
NCT07735143Major Depressive Disorder (MDD)
Shanghai Mental Health Center
Observational
150
Shanghai
2027-09-01
Recruiting
Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
NCT07170293Solid Cancers
DrugTunlametinib
Tianjin Medical University Second Hospital
Phase 2
15
Tianjin
2027-08-31
Not yet open
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
NCT07751003COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD, Hypercapnia
Sir Run Run Shaw Hospital
Not applicable
236
Zhengzhou, Changsha, Hangzhou, Wenling
2027-08-01
Not yet open
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases
NCT07389499IgA Nephropathy (IgAN), Membranous Nephropathy, ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN), Refractory Podocytopathy
Grit Biotechnology
Phase EARLY_PHASE1
30
Shanghai
2027-08
Not yet open
Combination Immunotherapy Targeting Sarcomas
NCT04433221Sarcoma, Osteoid Sarcoma, Ewing Sarcoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2027-07-01
Not yet open
Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial
NCT04980703Sleep Initiation and Maintenance Disorders
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
102
Shanghai
2027-07-01
Not yet open
Lentiviral Gene Therapy for CGD
NCT03645486Chronic Granulomatous Disease
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-07-01
Not yet open
Improving Quality of Informal Care for People With Schizophrenia
NCT07781748Schizophrenia
Chinese University of Hong Kong
Not applicable
228
Chengdu
2027-07-01
Not yet open
CAR-T Immunotherapy Targeting CD19- ALL
NCT04016129B-cell Leukemia
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-07-01
Not yet open
Universal CAR-T Cells Targeting AML
NCT05995041Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
Phase 1
30
Shenzhen
2027-06-30
Not yet open
Engineered Dendritic Cell Vaccines for Multiple Myeloma
NCT06435910Multiple Myeloma or Plasmacytoma
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2027-06-30
Not yet open
Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
NCT06435897Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)
NCT03645460Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-06-30
Not yet open
SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection
NCT03217617SCID, X-Linked
Shenzhen Geno-Immune Medical Institute
Phase 1/2
10
Shenzhen
2027-06-30
Not yet open
Combination Immunotherapy Targeting Melanoma
NCT06739226Melanoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
cfMSC Stem Cell Therapy Targeting COPD
NCT07477600Chronic Obstructive Pulmonary Disease (COPD)
DrugClonal fetal MSCs
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
Universal 4SCAR7U Targeting CD7-positive Malignancies
NCT05995028T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia, NK Cell Lymphoma
Shenzhen Geno-Immune Medical Institute
Phase 1
30
Shenzhen
2027-06-30
Not yet open
cfMSC Therapy for Diabetes
NCT07495956Type II Diabetes Mellitus
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
Universal CAR-T Cells Targeting Multiple Myeloma
NCT06006741Multiple Myeloma in Remission
Shenzhen Geno-Immune Medical Institute
Phase 1
20
Shenzhen
2027-06-30
Not yet open
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
NCT07501156Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
IT and IV Lentiviral Gene Therapy for X-ALD
NCT03727555X-linked Adrenoleukodystrophy
Shenzhen Geno-Immune Medical Institute
Not applicable
30
Shenzhen
2027-06-01
Not yet open
Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD
NCT07046338Metachromatic Leukodystrophy (MLD)
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-06-01
Not yet open
CD19/70 Bi-specific CAR-T Cell Therapy
NCT05436496B Cell Malignancies
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-01
Not yet open
DLL3 CAR-T Therapy Targeting Brain Tumors
NCT07180927Glioblastoma of Cerebellum
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-01
Not yet open
Multi-4SCAR-T Therapy Targeting Breast Cancer
NCT04430595Breast Cancer
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-06-01
Not yet open
Multi-CAR-T Cells Targeting B Cell Lymphomas
NCT04429438B Cell Lymphoma (BCL)
Shenzhen Geno-Immune Medical Institute
Phase 1/2
11
Shenzhen
2027-06-01
Not yet open
Lentiviral FIX Gene Therapy
NCT03961243Hemophilia B
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2027-06-01
Not yet open
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276
NCT04432649Solid Tumor
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-06-01
Not yet open
Lentiviral FVIII Gene Therapy
NCT03217032Hemophilia A
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2027-06-01
Not yet open
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
NCT03356782Sarcoma, Osteoid Sarcoma, Ewing Sarcoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2027-06-01
Not yet open
CAR-T Cells Targeting Autoimmune Diseases
NCT05459870Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-01
Not yet open
CD19/22 Bi-specific CAR-T Cell Therapy
NCT05432882B Cell Malignancies
Shenzhen Geno-Immune Medical Institute
Phase 1/2
60
Shenzhen
2027-06-01
Not yet open
Immunotherapy Treating GI Cancer
NCT03614650Cancer
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-06-01
Not yet open
Antigen-specific T Cells Against Lung Cancer
NCT03356808Lung Cancer
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2027-06-01
Not yet open
Direct Lentiviral Injection Gene Therapy for MLD
NCT03725670Metachromatic Leukodystrophy (MLD)
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-05-31
Not yet open
A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT07676006Relapsed/Refractory Acute Myeloid Leukemia (AML)
Grit Biotechnology
Phase EARLY_PHASE1
36
Shenzhen
2027-05
Not yet open
Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
NCT07698223Diabetic Nephropathy
Chen Xiangmei
Phase 4
410
Beijing, Chongqing, Dalian, Shanghai, Hangzhou
2027-03-01
Not yet open
Effectiveness of the MindBridge Mobile Health Module for Young Adults at Risk of Suicide
NCT07767604Suicidal Ideation
Jiangsu Medical College
Not applicable
84
Yancheng
2027-03
Not yet open
Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer
NCT07697079Gastric Cancer
Liu Yang
Observational
300
Jinan
2027-02-01
Not yet open
SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
NCT07470840Locally Advanced or Metastatic Renal Cell Carcinoma
DrugAnlotinib
Fujian Cancer Hospital
Phase 2
27
Fuzhou
2027-02-01
Recruiting
Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma
NCT06902012Relapsed/Refractory Diffuse Large B-cell Lymphoma
DrugAxicabtagene Ciloleucel
Zhujiang Hospital
Phase 1/2
15
Guangzhou
2027-02
Not yet open
RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients
NCT07056478Sarcopenia in Elderly
DrugsAclasta·Prolia·Denosumab
Prince of Wales Hospital, Shatin, Hong Kong
Phase 3
130
Hong Kong
2027-01-01
Not yet open
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
NCT07444463Schizophrenia, Bipolar Disorder, Major Depressive Disorder (MDD)
Central South University
Not applicable
400
Changsha
2027-01-01
Not yet open
TEER In dynaMic sEvere Functional Mitral Regurgitation (TIMER)
NCT07197021Mitral Regurgitation Functional
DrugGDMT
Sun Yat-sen University
Not applicable
540
Guangzhou
2027-01-01
Not yet open
Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment
NCT07615296Atherosclerotic Cardiovascular Disease (ASCVD)
Beijing Anzhen Hospital
Not applicable
6,000
Beijing
2027-01-01
Not yet open
Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis
NCT07466511Idiopathic Scoliosis
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
100
Wenzhou
2027-01-01
Not yet open
AI for Newborn Metabolic Screening
NCT07368504Inherited Metabolic Disorders
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
200,000
Hangzhou
2027-01-01
Not yet open
Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome
NCT07715760Functional Dyspepsia, Irritable Bowel Syndrome With Diarrhea
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Not applicable
120
Beijing
2027-01-01
Not yet open
A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia
NCT07758400Androgenetic Alopecia
DrugMinoxidil
Cheng Zhou
Not applicable
190
Beijing
2027-01-01
Not yet open
Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG
NCT07700524Coronary Artery Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
190
Nanjing
2027-01-01
Not yet open
Comparative Effects of Acceptance and Commitment Therapy, Cognitive Behavioral Therapy, and Treatment-as-Usual on Depression Among People With Marital Crisis
NCT07808021Depression - Major Depressive Disorder, Anxiety, Marital Conflict
Universiti Sains Malaysia
Not applicable
120
Yunfu
2027-01-01
Not yet open
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial
NCT07686796Local Advanced Rectal Cancer, PD-1 Inhibitor, PCSK9 Inhibitor, RCT
DrugsTafolecimab·Folfox·Sintilimab
Guangdong Provincial People's Hospital
Phase 3
148
Guangzhou
2027-01-01
Not yet open
Template-Guided Burr-Hole Drainage With Middle Meningeal Artery Coagulation for Chronic Subdural Hematoma
NCT07720687Chronic Subdural Hematoma
The Second Hospital of Anhui Medical University
Not applicable
440
Hefei
2027-01
Not yet open
Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
NCT07747402Type 2 Diabetes
DrugInsulin icodec
Xi'an International Medical Center Hospital
Phase 4
462
Xi'an
2027-01
Not yet open
Frontal vs Parietal Eminence Drainage for Chronic Subdural Hematoma
NCT07731620Chronic Subdural Hematoma
The Second Hospital of Anhui Medical University
Not applicable
440
Hefei, Huai'an, Yangzhou
2027-01
Not yet open
A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
NCT07138846Advanced Pancreatic Cancer
Lepu Biopharma Co., Ltd.
Phase 3
231
Shanghai
2027-01
Not yet open
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
NCT06429150Multiple Myeloma, Plasmacytoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2026-12-31
Not yet open
4SCAR19U T Cells Targeting B Cell Malignancies
NCT05995015B Cell Malignancies
Shenzhen Geno-Immune Medical Institute
Phase 1
30
Shenzhen
2026-12-31
Not yet open
GD2/PSMA Bi-specific CAR-T Cell Therapy
NCT05437315Solid Tumor
Shenzhen Geno-Immune Medical Institute
Phase 1/2
60
Shenzhen
2026-12-31
Not yet open
PSMA-specific CAR-T Cell Therapy
NCT04429451PSMA Positive Tumors or Tumor Tissues
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2026-12-31
Not yet open
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies
NCT04033302T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia, NK Cell Lymphoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2026-12-31
Not yet open
Immune Modulatory DC Vaccine Against Brain Tumor
NCT03914768Diffuse Intrinsic Pontine Glioma or Glioblastoma
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2026-12-31
Not yet open
Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
NCT03351829Beta-Thalassemia
Shenzhen Geno-Immune Medical Institute
Not applicable
20
Shenzhen
2026-12-31
Not yet open
Study on GD2 Positive Solid Tumors by 4SCAR-GD2
NCT02992210Solid Tumor
Shenzhen Geno-Immune Medical Institute
Phase 1/2
10
Shenzhen
2026-12-31
Not yet open
Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma
NCT03271632Multiple Myeloma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2026-12-31
Not yet open
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia
NCT03222674Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
Phase 1/2
10
Shenzhen
2026-12-31
Not yet open
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
NCT04637503Neuroblastoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2026-12-31
Not yet open
GD2/CD70 Bi-specific CAR-T Cell Therapy
NCT05438368Cancer Disease
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2026-12-31
Not yet open
A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
NCT07341672Healthy Adult Subject
DrugsClifutinib·Efavirenz·Fluconazole·Itraconazole
Sunshine Lake Pharma Co., Ltd.
Phase 1
80
Jinan
2026-12-31
Not yet open
Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders
NCT03123458Immune Related Disorder, Tissue Damage
DrugClonal fetal MSCs
Shenzhen Geno-Immune Medical Institute
Phase 1
100
Shenzhen
2026-12-31
Not yet open
Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
NCT07556120Generalized Myasthenia Gravis
Shenzhen MagicRNA Biotechnology Co., Ltd
Phase 1
6
Hefei
2026-12-31
Not yet open
Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies
NCT07345780CD7-Positive Hematological Malignancies
Donghua Zhang
Not applicable
28
Wuhan
2026-12-31
Not yet open
Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases
NCT07523282Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Sclerosis (SSc)
DrugHN2302
Shenzhen MagicRNA Biotechnology Co., Ltd
Phase 1
12
Hefei
2026-12-31
Not yet open
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
NCT05560373Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage
Wanbangde Pharmaceutical Group Co., LTD
Phase 4
60
Hangzhou
2026-12-31
Not yet open
Adaptive Digital Exercise Rehabilitation for Children After CHD Surgery
NCT07574463Congenital Heart Disease (CHD), Congenital Heart Disease in Children
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
130
Hangzhou
2026-12-30
Not yet open
PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
NCT07349979Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease, Stable GDMT
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,154
Nanjing
2026-12-30
Not yet open
Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction
NCT07331220Heart Failure With Preserved Ejection Fraction
DrugGDMT
Nanjing First Hospital, Nanjing Medical University
Not applicable
310
Nanjing
2026-12-30
Not yet open
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
NCT06136507Severe Hemophilia A
DrugFRSW107
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
76
Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen
2026-12-25
Not yet open
Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer
NCT07314203Gastric Cancer, Surgery
DrugApatinib Mesylate
Fujian Medical University
Phase 3
118
Fuzhou
2026-12-25
Not yet open
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408Pulmonary Fibrosis
DrugAdmilparant
Bristol-Myers Squibb
Phase 3
2,380
Hefei, Beijing, Shenzhen, Guangzhou, Shenzhen Shi, Zhengzhou, Shijiazhuang, Yichang Shi
2026-12-16
Recruiting
Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care
NCT07372027Hemodialysis Access, Arteriovenous Fistula, Arteriovenous Fistula Cannulation, Vascular Access
Suzhou Municipal Hospital of Anhui Province
Not applicable
100
Suzhou
2026-12-15
Not yet open
A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24 Weeks in Patients With PNH.
NCT07747090Paroxysmal Nocturnal Hemoglobinuria
DrugsFXS6837·Eculizumab
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 3
90
Tianjin
2026-12-10
Not yet open
A Study of TIL in Advanced Solid Tumors (CZ)
NCT07294872Solid Tumor, Adult
Shanghai Juncell Therapeutics
Phase 1
30
Chengdu
2026-12-08
Not yet open
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease
NCT07718659Parkinson's Disease (PD), Parkinsonian Disorders
Qianfoshan Hospital
Phase 1
8
Jinan
2026-12-01
Not yet open
Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency
NCT07786571Type 2 Diabetes Mellitus (T2DM), Chronic Renal Insufficiency, Chronic Kidney Disease (Stages 3b-5), Glucose Homeostasis
DrugLinagliptin
Sun Yat-sen University
Not applicable
206
Guangzhou
2026-12-01
Not yet open
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma
NCT07575724Primary, Sarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
3,300
Hangzhou
2026-12-01
Not yet open
A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study
NCT07751497Vestibular Migraine
DrugsFlunarizine·Rimegepant
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
400
Hangzhou
2026-12-01
Not yet open
Nutritional Support on Outcomes and Cost-effectiveness for Patients at Risk
NCT05917418Malnutrition
Peking Union Medical College
Not applicable
400
Beijing
2026-12-01
Not yet open
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
NCT07815301Obstructive Hypertrophic Cardiomyopathy (oHCM)
First Affiliated Hospital of Wenzhou Medical University
Not applicable
286
Wenzhou
2026-12
Not yet open
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
NCT07790861Obesity, Overweight
DrugOrforglipron
Eli Lilly and Company
Phase 3
192
Chengdu, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Luoyang Shi, Nanchang
2026-12
Not yet open
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
NCT07189793Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Carcinoma in Situ of Bladder, Non-Muscle-Invasive Bladder Cancer
DrugsMitomycin C·Toripalimab·Gemcitabine
First Affiliated Hospital of Wenzhou Medical University
Phase 2
106
Wenzhou
2026-12
Not yet open
Clinical Efficacy of Modified Simiao Yongan Decoction and Endovascular Therapy for Diabetic Foot Ulcers
NCT07808502Diabetic Foot Ulcer, Damp-Heat Toxins Accumulation Syndrome
Chengdu University of Traditional Chinese Medicine
Not applicable
120
Chengdu
2026-12
Rows per page Showing 1–100 of 19052
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 19,052 studies
PhaseStudiesRecruitingShare
Not applicable4,6442,72924.4%
Observational3,9942,62121%
Phase 23,5962,24318.9%
Phase 32,2431,22811.8%
Phase 11,7391,1499.1%
Phase 1/21,2838756.7%
Phase 46733703.5%
Phase EARLY_PHASE15723753%
Phase 2/33081961.6%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Sun Yat-sen University490305
Fudan University472308
Second Affiliated Hospital, Zhejiang University, School of Medicine404278
Peking Union Medical College Hospital282187
Ruijin Hospital281180
AstraZeneca220112
Beijing Tiantan Hospital215151
Institute of Hematology & Blood Diseases Hospital, China214153
The First Affiliated Hospital with Nanjing Medical University205132
Cancer Institute and Hospital, Chinese Academy of Medical Sciences202132

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.